Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
2
Frequently Asked Questions
What is Market Cap of Virpax Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Virpax Pharmaceuticals Inc market cap is $18,800.00.
What is the 52-week high for Virpax Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Virpax Pharmaceuticals Inc 52 week high is $26.25 as of September 21, 2025.
What is the 52-week low for Virpax Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Virpax Pharmaceuticals Inc 52 week low is $0.01 as of September 21, 2025.
What is Virpax Pharmaceuticals Inc stock price today?
Virpax Pharmaceuticals Inc stock price today is $0.0151.
What was Virpax Pharmaceuticals Inc stock price yesterday?
Virpax Pharmaceuticals Inc stock price yesterday was $0.0122.
What is the PE ratio of Virpax Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Virpax Pharmaceuticals Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Virpax Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Virpax Pharmaceuticals Inc P/B ratio is -0.0098.
What is the 50-day moving average of Virpax Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Virpax Pharmaceuticals Inc 50-day moving average is $0.0664.
How many employess does Virpax Pharmaceuticals Inc has?